دورية أكاديمية

Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.

التفاصيل البيبلوغرافية
العنوان: Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
المؤلفون: Saraf, Sharada, Zhu, Xianming, Shrestha, Ruchee, Bonny, Tania S., Baker, Owen R., Beck, Evan J., Fernandez, Reinaldo E., Eby, Yolanda, Akinde, Olivia, Ruff, Jessica E., Caturegli, Patrizio, Redd, Andrew D., Bloch, Evan M., Quinn, Thomas C., Tobian, Aaron A. R., Laeyendecker, Oliver
المصدر: PLoS ONE; 6/9/2022, Vol. 17 Issue 6, p1-11, 11p
مصطلحات موضوعية: ANTIBODY formation, SARS-CoV-2, CONVALESCENT plasma, FC receptors, SYMPTOMS, COUGH, IMMUNOGLOBULIN M
مستخلص: The association between COVID-19 symptoms and antibody responses against SARS-CoV-2 is poorly characterized. We analyzed antibody levels in individuals with known SARS-CoV-2 infection to identify potential antibody-symptom associations. Convalescent plasma from 216 SARS-CoV-2 RNA+ individuals with symptomatology information were tested for the presence of IgG to the spike S1 subunit (Euroimmun ELISA), IgG to receptor binding domain (RBD, CoronaCHEK rapid test), and for IgG, IgA, and IgM to nucleocapsid (N, Bio-Rad ELISA). Logistic regression was used to estimate the odds of having a COVID-19 symptom from the antibody response, adjusting for sex and age. Cough strongly associated with antibodies against S1 (adjusted odds ratio [aOR] = 5.33; 95% CI from 1.51 to 18.86) and RBD (aOR = 4.36; CI 1.49, 12.78). In contrast, sore throat significantly associated with the absence of antibodies to S1 and N (aOR = 0.25; CI 0.08, 0.80 and aOR = 0.31; 0.11, 0.91). Similarly, lack of symptoms associated with the absence of antibodies to N and RBD (aOR = 0.16; CI 0.03, 0.97 and aOR = 0.16; CI 0.03, 1.01). Cough appeared to be correlated with a seropositive result, suggesting that SARS-CoV-2 infected individuals exhibiting lower respiratory symptoms generate a robust antibody response. Conversely, those without symptoms or limited to a sore throat while infected with SARS-CoV-2 were likely to lack a detectable antibody response. These findings strongly support the notion that severity of infection correlates with robust antibody response. [ABSTRACT FROM AUTHOR]
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19326203
DOI:10.1371/journal.pone.0264298